Telix Pharmaceuticals Ltd. (TLX)
9.43
+0.21
(+2.28%)
USD |
NASDAQ |
Jun 09, 16:00
9.43
0.00 (0.00%)
After-Hours: 20:00
Telix Pharmaceuticals EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Propanc Biopharma, Inc. | -7.09 |
| Mesoblast Ltd. | -- |
| Amplia Therapeutics Ltd. | -- |
| Agenus, Inc. | 1.023 |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | 3.013B |
| Earnings Yield | -0.22% |
| Operating Earnings Yield | 0.55% |
| Normalized Earnings Yield | -0.4751 |